Enanta Pharmaceuticals | Penjualan





Penjualan Perubahan Tanggal
AbbVie USD 16.62B 840M 2025-12
Amgen USD 9.9B 340M 2025-12
Anika Therapeutics USD 26.17M 12.58M 2025-03
Arrowhead Research USD 264.03M 7.56M 2025-12
AstraZeneca USD 15.5B 313M 2025-12
BioCryst Pharmaceuticals USD -86.95M 204.03M 2024-12
Biogen USD 2.28B 250M 2025-12
Bristol-Myers Squibb USD 12.5B 300M 2025-12
Enanta Pharmaceuticals USD 16.96M 50.68M 2024-12
Gilead Sciences USD 7.93B 130M 2025-12
GlaxoSmithKline GBP 8.62B 73M 2025-12
Halozyme Therapeutics USD 354M 148M 2025-09
Heron Therapeutics USD 32.81M 3.21M 2024-09
Incyte USD 1.51B 140M 2025-12
Insmed USD 142M 34.6M 2025-09
Ionis Pharmaceuticals USD 157M 295M 2025-09
J&J USD 24.6B 610M 2025-12
Karyopharm Therapeutics USD 30.54M 8.24M 2024-12
Ligand Pharmaceuticals USD 115.46M 67.83M 2025-09
Merck USD 16.4B 880M 2025-12
Neurocrine Biosciences USD 794.9M 107.4M 2025-09
Novartis USD 13.91B 144M 2025-09
Novavax USD 84.51M 330.97M 2024-09
Pfizer USD 17.58B 880M 2025-12
PTC Therapeutics USD 211M 32.1M 2025-09
Roche Holding CHF 15.65B 274.5M 2025-12
Sarepta Therapeutics USD 399.4M 211.69M 2025-09
Vertex Pharmaceuticals USD 3.08B 120M 2025-09


Enanta Pharmaceuticals Penjualan - Nilai saat ini, data historis, perkiraan, statistik, grafik dan kalender ekonomi - Feb 2026.